Transforming growth factor-β1 enhances the invasiveness of human MDA- MB-231 breast cancer cells by up-regulating urokinase activity

International Journal of Cancer

Volumn 75, Issue 5, 1998, Pages 721-730

  Farina, Antonietta R ^a   Coppa, Anna ^b   Tiberio, Antonella ^a   Tacconelli, Antonella ^a   Turco, Alessandra ^b   Colletta, Gulia ^c   Gulino, Alberto ^a,b   Mackay, Andrew R ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN; COLLAGEN; GELATIN; GELATINASE B; MATRIX METALLOPROTEINASE; PLASMIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE PLASMINOGEN ACTIVATOR; TRANSFORMING GROWTH FACTOR BETA1; UROKINASE;

ARTICLE; BASEMENT MEMBRANE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INDUCTION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; INVASIVE CARCINOMA; PRIORITY JOURNAL; PROGNOSIS;

BREAST NEOPLASMS; CASEINS; COLLAGEN; DRUG COMBINATIONS; HUMANS; LAMININ; MATRIX METALLOPROTEINASE 3; NEOPLASM INVASIVENESS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEOGLYCANS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION; URINARY PLASMINOGEN ACTIVATOR;

EID: 0032473479     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980302)75:5<721::AID-IJC10>3.0.CO;2-9     Document Type: Article

References (39)

1. ALBINI, A., IWAMOTO, Y., KLEINMAN, H.K., MARTIN, G.R., AARONSON, S.A., KOZLOWSKI, J.M. and MCEWAN, T.N., A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res., 47, 3239-3245 (1987).
2. ALBO, D., ARNOLETTI, J.P., CASTIGLIONI, A., GRANICK, M.S., SOLOMON, M.P., ROTHMAN, V.L. and TLSZYNSKI, G.P., Thrombospondin (TSP) and transforming growth factor beta 1 promote human A-549 lung carcinoma cell plasminogen activator inhibitor type 1 (PAI-1) production and stimulate tumor cell attachment. Biochem. biophys. Res. Comm., 203, 857-865 (1994).
3. ARNOLLETI, J.P., ALBO, D., GRANICK, M.S., SOLOMON, M.P., CASTIGLIONI, A., ROTHMAN, B.S. and TUSZYNSKI, G.P., Thrombospondin and transforming growth factor-beta1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells. Cancer, 76, 998-1005 (1995).
4. BARNARD, J.A., LYONS, R.M. and MUSES, H.L., Cell biology of transforming growth factor beta. Biochim. biophys. Acta, 1032, 79-87 (1990).
5. BASSET, P., BELLOCQ, J.P., WOLF, C., STOLL, I., HUNTIN, P., LIMBACKER, J.M., PODHAJCER, O.L., CHENARD, M.P., RIO, M.C. and CHAMBON, P., A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature (Lond.), 348, 699-704 (1990).
6. CHANG, H.S., GILLET, N., FIGARI, I., LOPEZ, A.R., PALLADINO, M.A. and DERYNCK, R., Increased transforming growth factor β expression inhibits cell proliferation in vitro, yet increases tumorigenicity and tumor growth of Meth A sarcoma cells. Cancer Res., 53, 4391-4398 (1993).
7. COTTAM, D.W. and REES, R.C., Regulation of matrix metalloproteinases: their role in tumor invasion and metastasis. Int. J. Oncol., 2, 861-872 (1993).
8. DANØ, K., ANDREASEN, P.A., GRONDAHL-HANSEN, J., KRISTENSEN, P., NIELSEN, L.S. and SKRIVER, L., Plasminogen activators, tissue degradation and cancer Adv. Cancer Res., 44, 139-266 (1985).
9. DUBLIN, E.A., BARNS, D.M., WANG, D.Y., KING, R.J. and LEVISON, D.A., TGFα and TGFβ expression in mammary carcinoma. J. Pathol., 170, 15-22 (1993).
10. FALCONE, D.J., MCCAFFREY, T.A., HAIMOVITZ-FRIEDMAN, A. and GARCIA, M., Transforming growth factor-β1 stimulates macrophage urokinase and release of matrix bound basic fibroblast growth factor. J. cell. Physiol., 155, 595-605 (1993).
11. FARINA, A.R., TIBERIO, A., TACCONELLI, A., CAPPABIANCA, L., GULINO, A. and MACKAY, A.R., Identification of plasminogen in Matrigel and its activation by plasminogen activators endogenous to this tumor basement membrane extract. Biotechniques, 21, 904-909 (1996).
12. FESTUCCIA, C., BOLOGNA, M., VICENTINI, C., TACCONELLI, A., MIANO, R., VIOLINI, S. and MACKAY, A.R., Increased matrix metalloproteinase-9 secretion in short term tissue cultures of prostatic tumor cells. Int. J. Cancer (Pred. Oncol.), 69, 1-8 (1996).
13. FOEKENS, J.A., SCHMITT, M., VAN PUTTEN, W.L.J., PETERS, H.A., BONTENBAL, M., JÄNICKE, F. and KLIJN, J.G.M., Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patients. Cancer Res., 52, 6101-6105 (1992).
14. HERRERA, R.E., MAKELA, T.P. and WEINBERG, R.A., TGFβ-induced growth inhibition in primary fibroblasts requires the retinoblastoma protein. Mol. Biol. Cell., 7, 1335-1342 (1996).
15. JÄNICKE, F., SCHMITT, M. and GRAEFF, H., Clinical relevance of urokinase-type and tissue type plasminogen activators and their type-1 inhibitor breast cancer. Semin. Thrombosis Hemostasis, 17, 303-332 (1991).
16. KALKHOVEN, E., ROELEN, B.A.J., DE WINTER, J.P., MUMMERY, C.L., VAN DEN EIJNDEN-VAN RAAIJ, A.J., VAN DER SAAG, P.T. and VAN DEN BURG, B., Resistance to transforming growth factor β and activin due to reduced receptor expression in human breast tumor cell lines. Cell Growth Differentiation, 6, 1151-1161 (1995).
17. KUBOTA, S., FRIDMAN, R. and YAMADA, Y. Transforming growth factor-β suppresses the invasiveness of human fibrosarcoma cells in vitro by increasing expression of tissue inhibitor of metalloproteinase. Biochem. biophys. Res. Comm., 176, 129-136 (1991).
18. LIOTTA, L.A. and STETLER-STEVENSON, W.G., Tumor invasion and metastasis an imbalance of positive and negative regulation. Cancer Res. (Suppl.), 51, 5054S-5059S (1991).
19. LUND, L.R., ELLIS, V., RONNE, E., PYKE, C. and DANØ, K., Transcriptional and posttranscriptional regulation of the receptor for urokinase-type plasminogen activator by cytokines and tumour promoters in the human lung carcinoma cell line A-549. Biochem. J., 310, 345-352 (1995).
20. MACKAY, A.R., BALLIN, M., PELLINA, M.D., FARINA, A.R., NASON, A.M., HARTZLER, J.L. and THORGEIRSSON, U.P., Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. Invasion Metastasis, 12, 168-184 (1992).
21. MACKAY, A.R., CORBITT, R.H., HARTZLER, J.L. and THORGEIRSSON, U.P., Basement membrane type IV collagen degradation: evidence for the involvement of a proteolytic cascade independent of metalloproteinases. Cancer Res., 50, 5997-6001 (1990a).
22. MACKAY, A.R., GOMEZ, D.E., COTTAM, D.W., REES, R.C., NASON, A.M. and THORGEIRSSON, U.P., Identification of the 72kDa (MMP-2) and 92kDa (MMP-9) gelatinase/type IV collagenase in preparations of laminin and Matrigel. Biotechniques, 15, 1048-1051 (1993).
23. MACKAY, A.R., HARTZLER, J.L., PELINA, M.D. and THORGEIRSSON, U.P., Studies on the ability of 65-kDa and 92-kDa tumor cell gelatinases to degrade type IV collagen. J. biol. Chem., 265, 21929-21934 (1990b).
24. MASSAGUÉ, J., ATTISANO, L. and WRANA, J.L., The TGF-β family and its cognate receptors. Trends Cell Biol., 4, 172-178 (1994).
25. MATRISIAN, L.M., GANSER, G.L., KERR, L.D. and WOOD, L.D., Negative regulation of gene expression by TGF-β. Mol. Reprod. Develop., 32, 111-120 (1992).
26. MIGNATTI, P.E., ROBBINS, E. and RIFKIN, D.B., Tumor invasion through the amniotic membrane: requirements for a proteolytic cascade. Cell, 47, 487-498 (1986).
27. MURRAY, P.A., BARRETT-LEE, P., TRAVERS, M., LUQMANI, Y., POWLES, T. and COOMBES, R.C., The prognostic significance of transforming growth factors in human breast cancer. Brit. J. Cancer, 67, 1408-1412 (1993).
28. OVERALL, CM., WRANA, J.L. and SODEK, J.J., Independent regulation of collagenase, 72kDa progelatinase and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-β. J. Biol. Chem., 264, 1860-1869 (1989).
29. RAMOS-DESIMONE, N., MOLL, U.M., QUIGLEY, J.P. and FRENCH, D.L., Inhibition of matrix metalloproteinase 9 activation by a specific monoclonal antibody. Hybridoma, 12, 349-363 (1993).
30. SANDLER, M.A., ZHANG, J.N., WESTERHAUSEN, D.R. and BILLADELLO, J., A novel protein interacts with the major transforming growth factor-beta responsive element in the plasminogen activator inhibitor type-1 gene. J. biol. Chem., 269, 21500-21504 (1994).
31. SATO, H., TAKINO, T., OKADA, Y., CAO, J., SHINAGAWA, A., YAMAMOTO, E. and SEIKI, M., A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature (Lond.). 370, 61-65 (1994).
32. SHIPLEY, G.K., PITTELKOW, M.R., WILLIE, J.J., SCOTT, R.E. and MOSES, H.L., Reversible inhibition of human prokeratinocyte proliferation by type-beta transforming growth factor-growth inhibition in serum-free medium. Cancer Res., 46, 2068-2071 (1986).
33. STAHL, A. and MUELLER, B.M., Binding of urokinase to its receptor promotes migration and invasion of human melanoma cells in vitro Cancer Res., 54, 3066-3071 (1994).
34. STEFANSSON, S. and LAWRENCE, D.A., The serpin PAI-1 inhibits cell migration by blocking integrin alphaV beta3 binding to vitronectin Nature (Loud.), 383, 441-443 (1996).
35. SUN, L., WU, G., WILSON, J.K.V., ZBOROWSKI E., YANG, J., RAJKARUNANAYAKE, I., WANG, J., GENTRY, L.E., WANG, X.F. and BRATTAIN, M.G., Expression of transforming growth factor beta type II receptor leads to reduced malignancy in human breast cancer MCF7 cells. J. biol. Chem., 269, 26449-26455 (1994).
36. TOTH, M., GERVASI, D.C. and FRIDMAN, R., Phorbol ester-induced cell surface association of matrix metalloproteinase-9 in human MCF10A breast epithelial cells. Cancer Res., 57, 3159-3167 (1997).
37. VISSCHER, D.W., HÖYHTYÄ, M., OTTOSEN, S.K., LIANG, C.M., SARKAR, F.H., CRISSMAN, J.D. and FRIDMAN, R., Enhanced expression of tissue inhibitor of metalloproteinases 2 (TIMP2) in the stroma of breast carcinomas correlates with tumour recurrence. Int. J. Cancer. 58, 1-6 (1994).
38. WAHL, S.M., ALLEN, J.B., WEEKS, B.S., WONG, H.L. and KLOTMAN, P.E., Transforming growth factor β enhances integrin expression and type IV collagenase secretion in human monocytes. Proc. nat. Acad. Sci (Wash.), 90, 4577-4581 (1993).
39. WAKEFIELD, L.M., COLLETTA, A.A., MCCUNE, B.K. and SPORN, M.B., Roles of transforming growth factors-beta in the genesis, prevention and treatment of breast cancer. Cancer Treat Res., 61, 97-136 (1992).